ADMA ADMA Biologics
$13.21
ADMA Biologics (ADMA) Earnings News
Earnings press releases, previews and reviews for ADMA Biologics (ADMA), newest first. Our most recent is review: ADMA Biologics Beats on ASCENIV Acceleration and Margin Strength, but Floor-Level Revenue Guidance and Slower Cash Conversion Temper the Quarter.
Wednesday
November 4, 2026
6:57 PM ET
ADMA Biologics Beats on ASCENIV Acceleration and Margin Strength, but Floor-Level Revenue Guidance and Slower Cash Conversion Temper the Quarter
Earnings Whispers · Review
Wednesday
November 4, 2026
4:05 PM ET
ADMA Biologics Reports Third Quarter 2026 Financial Results and Provides Business Update
Wednesday
October 28, 2026
12:45 PM ET
ADMA Needs Ascentiv's Summer Surge to Lift Revenue Off the Low End of Guidance
Earnings Whispers · Preview
Wednesday
October 28, 2026
7:00 AM ET
ADMA Biologics to Report Third Quarter 2026 Financial Results on November 4, 2026
Wednesday
August 5, 2026
4:05 PM ET
ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update
Wednesday
July 29, 2026
7:00 AM ET
ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026